WUXI X3EPURI Trademark

Trademark Overview


On Thursday, October 30, 2025, a trademark application was filed for WUXI X3EPURI with the United States Patent and Trademark Office. The USPTO has given the WUXI X3EPURI trademark a serial number of 99471750. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, March 18, 2026. This trademark is owned by WuXi XDC Cayman Inc.. The WUXI X3EPURI trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Research and development services of new pharmaceutical products; Research and development of antibody-drug conjugates; Research and development of conjugated antibodies; Product development for others; Biomedical research services; Scientific research in the nature of conducting clinical trials for others in the field of new pharmaceutical development; Product development consulting in the field of pharmaceuticals, anti-bodies, conjugated antibodies, chemical reagents

Custom manufacture of pharmaceuticals; Custom manufacturing of pharmaceuticals; Custom manufacture of pharmaceutical preparations, biomedical preparations, drug conjugates, anti-body drug conjugates, chemical reagents; Biomanufacturing for others of pharmaceuticals using biological organisms in the manufacturing process; Manufacturing services for others in the field of antibody drug conjugates and intermediates thereof
wuxi x3epuri

General Information


Serial Number99471750
Word MarkWUXI X3EPURI
Filing DateThursday, October 30, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, March 18, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Research and development services of new pharmaceutical products; Research and development of antibody-drug conjugates; Research and development of conjugated antibodies; Product development for others; Biomedical research services; Scientific research in the nature of conducting clinical trials for others in the field of new pharmaceutical development; Product development consulting in the field of pharmaceuticals, anti-bodies, conjugated antibodies, chemical reagents
Goods and ServicesCustom manufacture of pharmaceuticals; Custom manufacturing of pharmaceuticals; Custom manufacture of pharmaceutical preparations, biomedical preparations, drug conjugates, anti-body drug conjugates, chemical reagents; Biomanufacturing for others of pharmaceuticals using biological organisms in the manufacturing process; Manufacturing services for others in the field of antibody drug conjugates and intermediates thereof

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, October 30, 2025
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 30, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameWuXi XDC Cayman Inc.
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressGrand Cayman KY1-1104
KY

Trademark Events


Event DateEvent Description
Thursday, October 30, 2025NEW APPLICATION ENTERED
Thursday, October 30, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, February 11, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, March 15, 2026ASSIGNED TO EXAMINER
Wednesday, March 18, 2026NON-FINAL ACTION WRITTEN
Wednesday, March 18, 2026NON-FINAL ACTION E-MAILED
Wednesday, March 18, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED